Literature DB >> 31318099

Enantiomeric impurities in chiral catalysts, auxiliaries, and synthons used in enantioselective syntheses. Part 5.

Nimisha Thakur1, Rahul A Patil1, Mohsen Talebi1, Elizabeth R Readel1, Daniel W Armstrong1.   

Abstract

The enantiomeric excess of chiral starting materials is one of the important factors determining the enantiopurity of products in asymmetric synthesis. Fifty-one commercially available chiral reagents used as building blocks, catalysts, and auxiliaries in various enantioselective syntheses were assayed for their enantiomeric purity. The test results were classified within five impurities level (ie, <0.01%, 0.01%-0.1%, 0.1%-1%, 1%-10%, >10%). Previously from 1998 to 2013, several reports have been published on the enantiomeric composition of more than 300 chiral reagents. This series of papers is necessitated by the fact that new reagents are forthcoming and that the enantiomeric purity of the same reagent can vary from batch to batch and/or from supplier to supplier. This report presents chiral liquid chromatography (LC) and gas chromatography (GC) methods to separate enantiomers of chiral compounds and evaluate their enantiomeric purities. The accurate and efficient LC analysis was done using newly introduced superficially porous particle (SPP 2.7 μm) based chiral stationary phases (TeicoShell, VancoShell, LarihcShell-P, and NicoShell).
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  chiral separation; enantiomeric excess; enantiomeric impurity; enantioselective syntheses

Year:  2019        PMID: 31318099     DOI: 10.1002/chir.23086

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  1 in total

1.  Enantiomeric Separation of New Chiral Azole Compounds.

Authors:  Marziyeh E Kenari; Joshua I Putman; Ravi P Singh; Brandon B Fulton; Huy Phan; Reem K Haimour; Key Tse; Alain Berthod; Carl J Lovely; Daniel W Armstrong
Journal:  Molecules       Date:  2021-01-04       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.